CSBR Champions Oncology PE ratio, current and historical analysis

The current PE ratio of CSBR cannot be calculated, as the latest EPS of -$0.05 is negative. The most recent PE ratio recorded for Champions Oncology was 694.0 in October 2022.

CSBR PE ratio history

How has CSBR's PE ratio performed in the past

Over the last six years, the average PE ratio of Champions Oncology has been 526.5. Looking back at the last six years, CSBR's PE ratio peaked in the Jul 2021 quarter at 1,045, with a price of $10.45 and an EPS of $0.01. The Apr 2022 quarter marked the lowest point at 192, with a price of $7.68 and an EPS of $0.04.

Today
N/A
Average
526.5
Median
379.34
Minimum
192
Maximum
1,045

Champions Oncology PE ratio by year

Maximum annual decrease: -46.32% in 2022

Year PE ratio PE change Price EPS
2024 N/A N/A $4.85 -$0.54
2023 N/A N/A $4.92 -$0.39
2022 192 -46.32% $7.68 $0.04
2021 357.67 N/A $10.73 $0.03
2020 N/A N/A $7.72 -$0.18
2019 908 N/A $9.08 $0.01
2018 N/A N/A $4.34 -$0.13
2017 N/A N/A $2.65 -$0.64
2016 N/A N/A $3.85 -$1.2
2015 N/A N/A $7.32 -$2.2
2014 N/A N/A $10.92 -$1.33
2013 N/A N/A $5.28 -$1.44
2012 N/A N/A $8.04 -$2.28
2011 N/A N/A $12 -$1.32
2010 N/A N/A $9.24 -$1.08

Champions Oncology PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Oct 2024 N/A N/A $3.91 -$0.05
Jul 2024 N/A N/A $4.79 -$0.25
Apr 2024 N/A N/A $4.85 -$0.54
Jan 2024 N/A N/A $5.81 -$0.72
Oct 2023 N/A N/A $5.46 -$0.71
Jul 2023 N/A N/A $6.5 -$0.56
Apr 2023 N/A N/A $4.92 -$0.39
Jan 2023 N/A N/A $4.11 -$0.23
Oct 2022 694 140.41% $6.94 $0.01
Jul 2022 288.67 50.35% $8.66 $0.03
Apr 2022 192 -52.12% $7.68 $0.04
Jan 2022 401 23.13% $8.02 $0.02
Oct 2021 325.67 -68.84% $9.77 $0.03
Jul 2021 1,045 192.17% $10.45 $0.01
Apr 2021 357.67 N/A $10.73 $0.03

CSBR average PE ratio chart

What is the average PE ratio of CSBR for the past years
3-year avg
N/A
5-year avg
472
10-year avg
526.5
15-year avg
N/A

CSBR PE vs peers

What is CSBR's PE ratio compared to its peers
Stock name PE ratio Market cap
EXEL Exelixis Inc 20.36 $10.26B
CRL Charles River Laboratories International Inc 855.2 $8.75B
CLDX Celldex Therapeutics Inc N/A $1.36B
CSBR Champions Oncology Inc N/A $127.55M

Frequently asked questions

What is Champions Oncology's PE ratio?

The current price to earnings ratio of CSBR cannot be determined, as its EPS of -$0.05 is negative.

What is the 5-year average PE ratio for Champions Oncology (CSBR)?

The 5-year average price to earnings ratio for CSBR stock is 472.0.

What is the highest PE ratio for CSBR?

The highest quarterly PE ratio in the last six years has been 1,045 and it was in the Jul 2021 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.